Chronicle Offers Management to Patients With Advanced Signs and Symptoms of Heart Failure (COMPASS-HF)
Public ClinicalTrials.gov record NCT00643279. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
COMPASS-HF was a prospective, two-arm, randomized (1:1), multi-center, parallel controlled study. The purpose of the randomized study was to test the safety of an implantable hemodynamic monitor (IHM) and pressure sensor lead. The premise of this study was to compare the effectiveness of a novel heart failure management strategy based on information obtained from the IHM system in reducing heart failure morbidity compared to a strategy based on standard medical care alone.
Study identification
- NCT ID
- NCT00643279
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 277 participants
Conditions and interventions
Conditions
Interventions
Device · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2003 (Type not available)
- Primary completion
- Jun 2005 (Actual)
- Completion
- Apr 2013 (Actual)
- Last update posted
- Dec 22, 2023
2003 – 2013
United States locations
- U.S. sites
- 28
- U.S. states
- 20
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | — | — |
| Loma Linda University Medical Center | Loma Linda | California | — | — |
| UCLA Medical Center | Los Angeles | California | — | — |
| University of Southern California | Los Angeles | California | — | — |
| University of Florida - Shands | Gainesville | Florida | — | — |
| Crawford LongHospital | Atlanta | Georgia | — | — |
| Prairie Heart Institute | Springfield | Illinois | — | — |
| Parkview Memorial Hospital | Fort Wayne | Indiana | — | — |
| New England Medical Center | Boston | Massachusetts | — | — |
| St. Paul Heart | Saint Paul | Minnesota | — | — |
| Mid America Heart Institute | Kansas City | Missouri | — | — |
| Robert Wood Johnson Medical Center | New Brunswick | New Jersey | — | — |
| Newark Beth Israel | Newark | New Jersey | — | — |
| New York Presbyterian - Columbia | New York | New York | — | — |
| Duke University | Chapel Hill | North Carolina | — | — |
| University of Cincinnati | Cincinnati | Ohio | — | — |
| The Ohio State University | Columbus | Ohio | — | — |
| Oklahoma Cardiovascular Associates | Oklahoma City | Oklahoma | — | — |
| University of Oklahoma | Oklahoma City | Oklahoma | — | — |
| Hospital of the University of Pennsylvania | Philadelphia | Pennsylvania | — | — |
| Temple University Hospital | Philadelphia | Pennsylvania | — | — |
| University of Pittsburgh | Pittsburgh | Pennsylvania | — | — |
| Medical University of South Carolina | Charleston | South Carolina | — | — |
| Baptist Memorial Hospital | Germantown | Tennessee | — | — |
| St. Thomas Hospital | Nashville | Tennessee | — | — |
| St. Luke's Episcopal Hospital/Texas Heart | Houston | Texas | — | — |
| LDS Hospital | Salt Lake City | Utah | — | — |
| University of Washington Medical Center | Seattle | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00643279, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 22, 2023 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00643279 live on ClinicalTrials.gov.